NCT02330445View on ClinicalTrials.gov

6-Month Phase I/II Open Label PRTX-100 in Previous Rheumatoid Arthritis Study Participants and Sera Collection

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

April 18, 2016

Study Completion Date

November 30, 2016

Conditions
Arthritis, Rheumatoid
Interventions
DRUG

PRTX-100

6 micrograms PRTX-100 per kilogram of body weight administered via infusion

Trial Locations (1)

83814

Protalex Investigational Site, Coeur d'Alene

All Listed Sponsors
lead

Protalex, Inc.

INDUSTRY

NCT02330445 - 6-Month Phase I/II Open Label PRTX-100 in Previous Rheumatoid Arthritis Study Participants and Sera Collection | Biotech Hunter | Biotech Hunter